Association between the NFKB1-94ins/del ATTG polymorphism and cancer risk: An updated meta-analysis

Cancer Investigation

Volumn 32, Issue 7, 2014, Pages 311-320

  Duan, Wenyuan ^a   Wang, Erli ^a   Zhang, Fengquan ^a   Wang, Tongjian ^a   You, Xiangdong ^b   Qiao, Bin ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b SHANDONG CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Cancer genetics; Carcinogenesis; Risk and prevention

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPA B P105 SUBUNIT; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIAN; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; COLORECTAL CANCER; DNA POLYMORPHISM; ETHNICITY; GENE DELETION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; KIDNEY CANCER; KIDNEY CELL; META ANALYSIS; MOUTH SQUAMOUS CELL CARCINOMA; OVARY CANCER; PRIORITY JOURNAL; RENAL CELL CANCER; SENSITIVITY ANALYSIS;

CANCER GENETICS; CARCINOGENESIS; RISK AND PREVENTION;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; CARCINOMA, SQUAMOUS CELL; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDEL MUTATION; KIDNEY NEOPLASMS; MOUTH NEOPLASMS; NEOPLASMS; NF-KAPPA B P50 SUBUNIT; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; URINARY BLADDER NEOPLASMS;

EID: 84903943867     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2014.911881     Document Type: Article

References (51)

1. Sun XF, Zhang H. NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 2007;22: 1387-1398. (Pubitemid 47470331)
2. Beinke S, Ley SC. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 2004;382: 393-409. (Pubitemid 39243905)
3. Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin Jr., AS. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 1997;278: 1812-1815. (Pubitemid 27527651)
4. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr., RJ, Sledge Jr., GW. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997;17: 3629-3639. (Pubitemid 27281838)
5. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001;107: 7-11. (Pubitemid 32047405)
6. Biton S, Ashkenazi A. NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling. Cell 2011;145: 92-103.
7. Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999;45: 7-17. (Pubitemid 29036378)
8. Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL. Genetic variation in tumor necrosis factor andthe nuclear factor- kappaBcanonicalpathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2008;17: 3161-3169.
9. Huang B, Zhao J, Li H, He K-L, Chen Y, Mayer L, Unkeless JC, Xiong H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005;65: 5009-5014. (Pubitemid 40827306)
10. Mukhopadhyay T, Roth JA, Maxwell SA. Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma. Oncogene 1995;11: 999-1003.
11. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999;18: 6910-6924.
12. Chen FE, Ghosh G. Regulation of DNA binding by Rel/NFkappa B transcription factors: structural views. Oncogene 1999;18: 6845-6852.
13. Chen FE, Huang DB, Chen YQ, Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature 1998;391: 410-413.
14. Rayet B, Gélinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999;18: 6938-6947.
15. Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dorken B. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996;87: 4340-4347. (Pubitemid 26155031)
16. Bours V, Dejardin E, Goujon-Letawe F, Merville MP, Castronovo V. The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. Biochem Pharmacol 1994;47: 145-149. (Pubitemid 24045827)
17. Karban AS, Okazaki T, Panhuysen CIM, Gallegos T, Potter JJ, Bailey-Wilson JE, Silverberg MS, Duerr RH, Cho JH, Gregersen PK, Wu Y, Achkar J-P, Dassopoulos T, Mezey E, Bayless TM, Nouvet FJ, Brant SR. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004;13: 35-45. (Pubitemid 38072133)
18. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 2006;243: 47-54.
19. Bu H, Rosdahl I, Sun X-F, Zhang H. Importance of polymorphisms in NF-κB1 and NF-κBIα genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. J Cancer Res Clin Oncol 2007;133: 859-866. (Pubitemid 350218912)
20. Zhang P, Wei Q, Li X, Wang K, Zeng H, Bu H, Li H. A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet 2009;191: 73-77.
21. Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U. Polymorphisms in NFk B, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 2010;10:484.
22. Fan Y, Yu W, Ye P, Wang H, Wang Z, Meng Q, Duan Y, Liang X, An W. NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population. DNA Cell Biol 2011;30: 241-245.
23. Song S, Chen D, Lu J, Liao J, Luo Y, Yang Z, Fu X, Fan X, Wei Y, Yang L, Wang L, Wang J. NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS One 2011;6:e21726.
24. Lin CW, Hsieh YS, Hsin CH, Su CW, Lin CH, Wei LH, Yang SF, Chien MH. Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS One 2012;7:e35078.
25. Cheng CW, Su JL, Lin CW, Su CW, Shih CH, Yang SF, Chien MH. Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features. PLoS One 2013;8:e56130.
26. Li P, Gu J, Yang X, Cai H, Tao J, Yang X, Lu Q, Wang Z, Yin C, Gu M. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population. PLoS One 2013;8:e71604.
27. Zou YF, Yuan FL, Feng XL, Tao JH, Ding N, Pan FM, Wang F. Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis. Cancer Invest 2011;29: 78-85.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327: 557-560. (Pubitemid 37088507)
29. Higgins JPT, Thompson SG. Quantifying heterogeneity in ametaanalysis. Stat Med 2002;21: 1539-1558.
30. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006;295: 676-680. (Pubitemid 43209069)
31. Riemann K, Becker L, Struwe H, Nuckel H, Duhrsen U, Alakus H, Winde G, Neuhauser M, Rubben H, Schmitz KJ, Wohlschlaeger J, Schmid KW, Siffert W. No association of the NFKB1 insertion/ deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics 2006;16: 783-788. (Pubitemid 44632292)
32. Lewander A, Butchi AK, Gao J, He LJ, Lindblom A, Arbman G, Carstensen J, Zhang ZY, Sun XF, G Swedish Low-Risk Colorectal Cancer Study. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand J Gastroenterol 2007;42: 1332-1338. (Pubitemid 47537062)
33. Riemann K, Becker L, Struwe H, Rubben H, Eisenhardt A, Siffert W. Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecularmarker for the risk of recurrence in superficial bladder cancer. Int J Clin PharmacolTher 2007;45: 423-430. (Pubitemid 47243938)
34. Lehnerdt GF, Bankfalvi A, Grehl S, Adamzik M, Lang S, Schmid KW, Siffert W, Riemann K. No association of the NF-kappaB1 -94ins/delATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck region. Int J Immunopathol Pharmacol 2008;21: 827-832.
35. Burnik FS, Yalcin S. NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors. Chemotherapy 2009;55: 381-385.
36. Lo SS, Chen JH, Wu CW, Lui WY. Functional polymorphism of NFKB1 promotermay correlate to the susceptibility of gastric cancer in aged patients. Surgery 2009;145: 280-285.
37. Zhou B, Rao L, Li Y, Gao L, Wang Y, Chen Y, Xue H, Song Y, Peng Y, Liao M, Zhang L. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett 2009;275: 72-76.
38. Tang T, Cui S, Deng X, Gong Z, Jiang G, Wang P, Liao B, Fei Z, Xian S, Zeng D, Li J. Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese. DNA Cell Biol 2010;29: 9-12.
39. Zhou B, Qie M, Wang Y, Yan L, Zhang Z, Liang A, Wang T, Wang X, Song Y, Zhang L. Relationship between NFKB1 -94 insertion/ deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol 2010;21: 506-511.
40. Cai H, Sun L, Cui L, Cao Q, Qin C, Zhang G, Mao X, Wang M, Zhang Z, Shao P, Yin C. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma. Urol Int 2013;91: 206-212.
41. Huang D, Yang L, Liu Y, Zhou Y, Guo Y, Pan M, Wang Y, Tan Y, Zhong H, Hu M, Lu W, Ji W, Wang J, Ran P, Zhong N, Zhou Y, Lu J. Functional polymorphisms in NFκB1/IκBα predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese. Hum Genet 2013;132: 451-460.
42. Huo ZH, Zhong HJ, Zhu YS, Xing B, Tang H. Roles of functional NFKB1 and β-Tr CP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility. Genet Mol Res 2013;12: 3435-3443.
43. Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, Andee ZD, Ankathil R. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol 2013;37: 634-638.
44. Munafò MR, Flint J. Meta-analysis of genetic association studies. Trends Genet 2004;20: 439-444. (Pubitemid 39094573)
45. Zintzaras E, Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet 2007;53: 1-9.
46. Andersen V, Holst R, Kopp TI, Tjønneland A, Vogel U. Interactions between diet, lifestyle and IL10, IL1B, and PTGS2/COX-2 gene polymorphisms in relation to risk of colorectal cancer in a prospective Danish case-cohort study. PLo S One 2013;8:e78366.
47. Hutter CM, Mechanic LE, Chatterjee N, Kraft P, Gillanders EM, NCIG-ETT on behalf of the. Gene-environment interactions in cancer epidemiology: a national cancer institute think tank report. Genet Epidemiol 2013;37: 643-657.
48. Liu J, Huang J, Zhang Y, Lan Q, Rothman N, Zheng T, Ma S. Identification of gene-environment interactions in cancer studies using penalization. Genomics 2013;102: 189-194.
49. Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, Fasching PA, Hopper JL, et al. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet 2013;9:e1003284.
50. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthyMI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, et al. Finding the missing heritability of complex diseases. Nature 2009;461: 747-753.
51. Saidak Z, Mentaverri R, Brown EM. The role of the calciumsensing receptor in the development and progression of cancer. Endocr Rev 2009;30: 178-195.